CABA Cabaletta Bio Inc

Price (delayed)

$7.47

Market cap

$186.21M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.47

Enterprise value

$88.94M

Highlights
Cabaletta Bio's quick ratio has decreased by 36% YoY but it has increased by 23% QoQ
CABA's net income has dropped by 70% year-on-year and by 7% since the previous quarter
The equity has contracted by 22% YoY and by 6% from the previous quarter

Key stats

What are the main financial stats of CABA
Market
Shares outstanding
24.93M
Market cap
$186.21M
Enterprise value
$88.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$35.56M
EBITDA
-$35.16M
Free cash flow
-$31.02M
Per share
EPS
-$1.47
Free cash flow per share
-$1.29
Book value per share
$4.29
Revenue per share
$0
TBVPS
$4.46
Balance sheet
Total assets
$107.28M
Total liabilities
$3.97M
Debt
$0
Equity
$103.31M
Working capital
$101.79M
Liquidity
Debt to equity
0
Current ratio
26.65
Quick ratio
25.71
Net debt/EBITDA
2.77
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-30.2%
Return on equity
-31.3%
Return on invested capital
-400.5%
Return on capital employed
-34.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CABA stock price

How has the Cabaletta Bio stock price performed over time
Intraday
-0.93%
1 week
-12.73%
1 month
-26.98%
1 year
2.19%
YTD
-40.14%
QTD
-32.7%

Financial performance

How have Cabaletta Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$35.65M
Net income
-$35.56M
Gross margin
N/A
Net margin
N/A
CABA's net income has dropped by 70% year-on-year and by 7% since the previous quarter
The operating income has plunged by 58% YoY and by 5% from the previous quarter

Growth

What is Cabaletta Bio's growth rate over time

Valuation

What is Cabaletta Bio stock price valuation
P/E
N/A
P/B
1.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
CABA's EPS is down by 2.1% QoQ
CABA's price to book (P/B) is 28% lower than its last 4 quarters average of 2.4
The equity has contracted by 22% YoY and by 6% from the previous quarter

Efficiency

How efficient is Cabaletta Bio business performance
Cabaletta Bio's ROE has plunged by 97% YoY and by 13% from the previous quarter
Cabaletta Bio's return on assets has shrunk by 95% YoY and by 13% QoQ
The ROIC has soared by 86% YoY and by 9% from the previous quarter

Dividends

What is CABA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CABA.

Financial health

How did Cabaletta Bio financials performed over time
Cabaletta Bio's quick ratio has decreased by 36% YoY but it has increased by 23% QoQ
The current ratio has contracted by 35% YoY but it has grown by 22% from the previous quarter
CABA's debt is 100% smaller than its equity
The equity has contracted by 22% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.